Literature DB >> 16319325

Pulmonary arterial hypertension: an autoimmune disease?

L Mouthon, L Guillevin, M Humbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16319325     DOI： 10.1183/09031936.05.00112105

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

Review 1.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

2.  T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.

Authors:  E D Austin; M T Rock; C A Mosse; C L Vnencak-Jones; S M Yoder; I M Robbins; J E Loyd; B O Meyrick
Journal:  Respir Med       Date:  2009-10-31       Impact factor: 3.415

3.  Associated pulmonary arterial hypertension in connective tissue diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-04

Review 4.  A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

Authors:  Wolfgang M Kuebler; Mark R Nicolls; Andrea Olschewski; Kohtaro Abe; Marlene Rabinovitch; Duncan Stewart; Stephen Y Chan; Nicholas W Morrell; Stephen L Archer; Edda Spiekerkoetter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-07       Impact factor: 5.464

Review 5.  The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

Authors:  Nada Kherbeck; Mathieu C Tamby; Guillaume Bussone; Hanadi Dib; Frederic Perros; Marc Humbert; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

6.  Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension.

Authors:  Jacob J Chabon; Liya Gebreab; Rahul Kumar; Elias Debella; Takeshi Tanaka; Dan Koyanagi; Alexandra Rodriguez Garcia; Linda Sanders; Mario Perez; Rubin M Tuder; Brian B Graham
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

7.  Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension?

Authors:  S J Arends; J G M C Damoiseaux; A M Duijvestijn; L Debrus-Palmans; M Vroomen; K A Boomars; H-P Brunner-La Rocca; C P M Reutelingsperger; J W Cohen Tervaert; P van Paassen
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

8.  Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Stephen L Archer; Albert Defelice; Steven Evans; Monica Fiszman; Thomas Martin; Muriel Saulnier; Marlene Rabinovitch; Ralph Schermuly; Duncan Stewart; Hubert Truebel; Gennyne Walker; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

9.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

Review 10.  Vasculitis: mechanisms involved and clinical manifestations.

Authors:  Loic Guillevin; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.